首页> 外文期刊>International Journal of Preventive Medicine >Pulmonary Tuberculosis in Mumbai, India: Factors Responsible for Patient and Treatment Delays
【24h】

Pulmonary Tuberculosis in Mumbai, India: Factors Responsible for Patient and Treatment Delays

机译:印度孟买的肺结核:造成患者和治疗延误的因素

获取原文
获取外文期刊封面目录资料

摘要

Purpose: To determine the factors responsible for patient delay and treatment delay in newly diagnosed sputum smear-positive pulmonary tuberculosis (TB) patients. Methods: Study subjects ( N = 150) were randomly selected from municipal health centers in Mumbai, India. Duration of symptoms, treatment, and reason for delay were assessed using interviews and medical records. We defined patient delay as presentation to a health care provider (HCP) 20 days of the onset of TB-related symptoms and treatment delay as therapy initiated more than 14 days after the first consultation (for TB-related symptoms) with an HCP. Results: Of the 150 subjects, 29% had patient delays and 81% had treatment delays. In multivariable analysis, patient delay was significantly associated with the self-perception that initial symptoms were due to TB [odds ratio (OR) = 3.8, 95% confidence interval (CI) = 1.1–12.6] and perceived inability to pay for care (OR = 2.9, 95% CI = 1.2–7.1). Treatment delay was significantly associated with consulting a non-allopathic provider (OR = 12.3, 95% CI = 1.4–105) and consulting 3 providers (OR = 5.0, 95% CI = 1.4–17.4). Patient interval was half the treatment interval (median days: 15 vs. 31). Women were slightly more likely to experience patient and treatment delays than men. For two-thirds of the patients, another TB patient was a source of TB-related knowledge, while health education material (16%) and television (10%) played a smaller role. Conclusion: Treatment delay, primarily due to diagnosis delay, was a greater problem than patient delay. Expanding public–public and public–private partnerships and regular training sessions for HCPs might decrease treatment delay. Media coverage and cured TB patients as peer advocates may help to reinforce TB-related health education messages.
机译:目的:确定新诊断的痰涂片阳性肺结核(TB)患者中导致患者延迟和治疗延迟的因素。方法:从印度孟买的市政卫生中心中随机选择研究对象(N = 150)。使用访谈和病历评估症状的持续时间,治疗和延误的原因。我们将患者延误定义为向结核病相关症状发作> 20天的医疗服务提供者(HCP)的陈述,而治疗延误定义为首次就HCP进行咨询(针对结核病相关症状)后超过14天开始治疗。结果:在150名受试者中,有29%的患者有延误,有81%的患者有延误。在多变量分析中,患者的延迟与最初症状归因于结核病的自我感觉显着相关[比值比(OR)= 3.8,95%置信区间(CI)= 1.1-12.6]和感觉到无力支付治疗费用( OR = 2.9,95%CI = 1.2-7.1)。延迟治疗与咨询非自恋者(OR = 12.3,95%CI = 1.4–105)和咨询> 3个提供商(OR = 5.0,95%CI = 1.4–17.4)显着相关。患者间隔是治疗间隔的一半(中位数:15对31)。女性比男性更有可能经历患者和治疗的延误。对于三分之二的患者,另一位结核病患者是与结核病相关知识的来源,而健康教育材料(16%)和电视(10%)的作用较小。结论:主要由于诊断延迟而导致的治疗延迟比患者延迟更大。扩大公立,公立和公私合营伙伴关系以及针对HCP的定期培训课程可能会减少治疗延迟。作为同伴倡导者,媒体报道和治愈的结核病患者可能有助于加强与结核病有关的健康教育信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号